Akut Radyasyon Sendromu veya Total Vücut Işınlamasında Profilaktik veya Terapotik Antibiyoterapi
Özet
Akut Radyasyon Sendromu (ARS) ve total vücut ışınlaması sonrasında gelişen derin immünosupresyon ile kutanöz ve mukozal bariyerlerin bütünlüğünün bozulması, hastaları ölümcül fırsatçı enfeksiyonlara karşı savunmasız bırakmaktadır. Radyasyon dozuna bağlı olarak hematopoetik, gastrointestinal, kutanöz ve nörovasküler sistemler değişken derecelerde etkilenmekte; lenfopeni, nötropeni ve mukozal harabiyet gibi patofizyolojik süreçler tetiklenmektedir. Bu klinik tabloda mortaliteyi azaltmak adına erken medikal müdahale, intravenöz hidrasyon, sitokin büyüme faktörlerinin kullanımı ve özellikle profilaktik ile terapötik antibiyoterapi stratejileri hayati önem taşımaktadır. Enfeksiyon yönetiminde hastalar nötrofil düzeylerine ve klinik durumlarına göre düşük veya yüksek riskli olarak sınıflandırılarak ampirik tedaviler titizlikle şekillendirilir. Nötropenik ateş durumunda geniş spektrumlu antipseudomonal ajanlarla intravenöz monoterapi ya da kombinasyon protokolleri uygulanırken; mukozit veya dekübit gibi durumlarda dirençli gram-pozitif etkenlere yönelik vankomisin, inatçı ateş varlığında ise flukonazol veya vorikonazol gibi antifungaller tedaviye eklenir. Viral reaktivasyon riskine karşı asiklovir veya gansiklovir profilaksisi, T-yardımcı hücre düşüklüğünde ise Pneumocystis jirovecii takibi elzemdir. Sonuç olarak, ARS vakalarında lokal direnç verileri ve ilaç toksisitesi gözetilerek yürütülen multidisipliner klinik yaklaşımlar, sağ kalım oranlarını optimize etmenin ve çoklu organ yetmezliğini önlemenin temelini oluşturmaktadır.
Acute Radiation Syndrome (ARS) and total body irradiation cause profound immunosuppression alongside the systematic disruption of cutaneous and mucosal barriers, rendering patients highly susceptible to lethal opportunistic infections. Depending on the exposure dose, the hematopoietic, gastrointestinal, cutaneous, and neurovascular systems are progressively affected, triggering critical pathophysiological cascades such as lymphopenia, severe neutropenia, and mucosal damage. To mitigate mortality, rapid medical management encompassing intravenous hydration, early administration of cytokine growth factors, and targeted prophylactic or therapeutic antibiotherapy is paramount. Patient stratification into low- and high-risk categories based on neutropenia duration guides empirical antimicrobial selection. Neutropenic fever necessitates broad-spectrum antipseudomonal agents as intravenous monotherapy or combined regimens, with glycopeptides like vancomycin reserved for specific gram-positive indications. Persistent fever prompts the introduction of antifungals like fluconazole or voriconazole, whereas heightened viral reactivation risks of latent pathogens like HSV and CMV demand prophylactic interventions with acyclovir or ganciclovir. Monitoring CD4 counts remains crucial to addressing opportunistic pathogens like Pneumocystis jirovecii. Ultimately, leveraging local resistance data and implementing comprehensive supportive care are essential to preventing multi-organ failure and maximizing survival outcomes in irradiated individuals.
Referanslar
Dainiak N, Gent RN, Carr Z, Schneider R, et all. Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep. 2011;5(3):183-201.
Dainiak N. Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res. 2018:1;59(suppl 2):54-64.
López M, Martín M. Medical management of the acute radiation syndrome. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2011:16(4), 138–146.
Goans RE, Flynn DF. Acute radiation syndrome in humans. Medical consequences of radiological and nuclear weapons. Falls Church: Office of The Surgeon General United States Army, 2012;17-38.
López M, Martín M. Medical management of the acute radiation syndrome. Rep Pract Oncol Radiother. 2011; 13;16(4):138-46.
Schaue D, McBride WH. T lymphocytes and normal tissue responses to radiation. Front Oncol 2012;2:119–34.
Dainiak N. Biology and Clinical Features of Radiation Injury in Adults. UpToDate. www.uptodate.com (1 August 2017, date last accessed).
Kumar KS, Srinivasan V, Toles RE et al. High-dose antibiotic therapy is superior to a 3-drug combination of prostanoids and lipid A derivative in protecting irradiated canines. J Radiat Res 2002;43:361–70.
Wingard JR, Dainiak N. Treatment of Radiation Injury in the Adult. UpToDate. www.uptodate.com (1 August 2017, date last accessed).
Dainiak N. Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res. 2018:1;59(suppl 2):54-64.
Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56–93.
Slavin MA, Osborne B, Adams R et al. Efficacy and safety of flucanozole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized double-blind study. J Infect Dis 1995;171:1545–52.
Mastromarino, A., & Wilson, R. (1976). Antibiotic radioprotection of mice exposed to supralethal whole-body irradiation independent of antibacterial activity. Radiation research, 68(2), 329-338.
Gafter-Gvili A, Fraser A, Paul M et al. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005;142:979–95.
Christensen DM, Iddins CJ, Parrillo SJ, Glassman ES, Goans RE. Management of ionizing radiation injuries and illnesses, part 4: acute radiation syndrome. Journal of Osteopathic Medicine, 2014; 114(9), 702-711.
Asano S. Multi-organ involvement: lessons from the experience of one victim of the Tokai-mura criticality accident. In: Fliedner TM, Meineke V, Akashi M et al. (eds). Advanced Radiation Workshop on radiation-induced multi-organ involvement and failure: a challenge for pathogenetic, diagnostic and therapeutic approaches and research. Brit J Radiol 2005;(Suppl.) 27:9–12.
Heslet LB CN-C, S. (2012). Acute radiation syndrome(ARS)–treatment of the reduced host defense. International journal of general medicine, 5, 105.
